Recommended Treatment Approach for Substance Use Disorder (SUD)
The recommended treatment approach for Substance Use Disorder (SUD) is a combination of pharmacotherapy and behavioral therapy, with specific medications and therapies tailored to the particular substance of abuse.
Evidence-Based Treatment Framework
Combination Therapy Approach
- Combined pharmacotherapy and behavioral therapy is superior to usual care alone for treating SUDs 1
- This combination approach yields better outcomes for morbidity, mortality, and quality of life than either modality alone 1
Substance-Specific Pharmacotherapy
For Opioid Use Disorder:
First-line medications:
Implementation considerations:
For Alcohol Use Disorder:
- First-line medications:
- Naltrexone (oral 50mg daily or extended-release injectable) - reduces alcohol consumption 3
- Acamprosate - helps maintain abstinence
- Disulfiram - creates aversive reaction to alcohol consumption
For Other SUDs:
- Tobacco: Nicotine replacement therapy, bupropion, varenicline 1
- Stimulants (cocaine/methamphetamine): No FDA-approved medications yet, but contingency management shows strong efficacy 1
- Cannabis: No FDA-approved medications currently available 1
Behavioral Therapy Components
Cognitive Behavioral Therapy (CBT):
Other effective behavioral approaches:
Implementation Algorithm
Assessment and Diagnosis:
- Screen for specific substance(s) of abuse
- Evaluate for psychiatric comorbidities (common in SUD and affect treatment approach) 1
- Assess readiness for change and treatment preferences
Select Pharmacotherapy Based on Substance:
- Opioids → Methadone, buprenorphine, or naltrexone
- Alcohol → Naltrexone, acamprosate, or disulfiram
- Tobacco → Nicotine replacement, buprenorphine, varenicline
- Stimulants → Focus on behavioral interventions while considering clinical trials
Integrate Behavioral Therapy:
- CBT should be offered concurrently with pharmacotherapy 1
- Other evidence-based behavioral therapies can be substituted based on availability and patient response
Provide Comprehensive Care:
Common Pitfalls and Considerations
- Undertreatment: Only 11.2% of inmates with SUD receive professional treatment 1, and many patients in the general population remain untreated
- Medication adherence: Implement compliance-enhancing techniques for all treatment components 3
- Comorbidities: SUDs often co-occur with psychiatric conditions that require concurrent treatment 5
- Barriers to implementation: Limited adoption of pharmacotherapies despite clinical promise 6
- Treatment initiation barriers: Homelessness and recent arrest are associated with lower odds of initiating behavioral treatment 7
Special Considerations
- Timing of intervention: Treatment can be administered during pretreatment, detoxification, or long-term recovery phases 1
- Integrated care: SUD treatment should be integrated into HIV prevention and treatment services for those at risk 1
- Telehealth options: Consider extended hours, mobile clinics, pharmacy delivery services, and walk-in options to improve access 1
With these evidence-based treatment approaches, successful outcomes for SUD are as likely as for other chronic diseases such as diabetes, hypertension, and asthma 1.